Expression of combinatorial immunoglobulins in macrophages in the tumor microenvironment

PLoS One. 2018 Sep 21;13(9):e0204108. doi: 10.1371/journal.pone.0204108. eCollection 2018.

Abstract

Recent evidence indicates the presence of macrophage subpopulations that express the TCRαβ in chronic inflammatory diseases such as tuberculosis and atherosclerosis and in the tumor microenvironment. Here, we demonstrate that a second subpopulation of macrophages expresses rearranged heavy and light chain immunoglobulins. We identify immunoglobulin expression in human and murine monocytes, in ex vivo differentiated macrophages and macrophages from the tumor microenvironment of five randomly selected distinct human tumor entities. The immunoglobulin heavy and light chains are expressed in a small macrophage subfraction (~3-5%) as combinatorial and individual-specific immune receptors. Using Sanger sequencing and deep sequencing, we routinely find markedly restricted Ig repertoires in monocytes/macrophages compared to normal B cells. Furthermore, we report the complete Ig heavy and light chain sequences of a fully functional immunoglobulin from a single tumor-associated macrophage. These results demonstrate that Ig expression is a defining feature of monocytes and also macrophages in the tumor microenvironment and thus reveal an as yet unrecognized modus operandi of host defense in professional phagocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • B-Lymphocytes / metabolism
  • Clone Cells
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Immunoglobulin Heavy Chains / chemistry
  • Immunoglobulin Heavy Chains / metabolism
  • Immunoglobulin Light Chains / chemistry
  • Immunoglobulin Light Chains / metabolism
  • Immunoglobulins / metabolism*
  • Macrophages / metabolism*
  • Macrophages / pathology*
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monocytes / metabolism
  • Myeloid Progenitor Cells / metabolism
  • Transcriptome / genetics
  • Tumor Microenvironment*

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Immunoglobulins

Grants and funding

WEK and TF were supported by a grant from "Stiftung für Pathobiochemie und Molekulare Diagnostik" der "Deutschen Vereinten Gesellschaft für Klinische Chemie und Labormedizin" (FUCHS 5-5015) and the intramural funding program MEAMEDMA of the Medical Faculty Mannheim of Heidelberg University, Germany to TF (81000186). The companies iRepertoire inc., Aesculabor Hamburg and Bioscientia provided support in the form of salaries for authors [CW, JH, KP and WEK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.